Aminoglycosides Flashcards
Aminoglycoside options
-Amikacin
-Gentamicin
Gentamicin formulations
- Gentocin- sterile injectable solution (IM, SC, IU but given IV off label)
- Otomax, Mometamaxx
-topical ointments for otitis externa
-includes an antifungal - Topagen
-topical spray for dermal lesions
Amikacin formulations
1.Amiglyde-V
-sterile injectable solution
-labelled only for IU use in mares but often given off label IV in small animals and equine
**Generally more potent than Gentomicin.. but narrower spectrum of activity
Neomycin
-various calf scour boluses, water soluble powders for food animals
-skin/ear ointments
-antimicrobial preservative in many vaccines
Apramycin
-Apralan oral solution for swine scours caused by E. coli
Aminoglycasides mechanism of action
Bind to bacterial ribosomal 30S subunit
-causes incorrect tRNA translation
-disrupts bacterial protein synthesis
-results in increased bacterial membrane permeability
Factors allowing for aminogylcosides to access the bacteria
- Need oxygen so very poor efficacy in anaerobic environment
- Local pH
-basic pH= aminoglycosides non ionized, easier to transport in but can diffuse out
-acidic pH= Aminoglycosides more ionized, less transport in but then ion trapped - Purulent material in abscesses can inactivate aminoglycosides
Aminoglycosides spectrum of activity
- gram -
-especially enteric bacteria (including pseudomonas) - Activity against staph spp
-includes some MRSA/MRSP - Some activity against enterococcus, mycobacteria, mycoplasma
What are aminoglycosides not effective against?
- less activity against strep spp
*especially amikacin - intracellular pathogens
-including salmonella - Anaerobes
Ways Aminoglycosides can become Resistance
- Plasmid-mediated enzymes degrade aminoglycosides and prevent binding to ribosome 30S subunit
**most important for determining clinical susceptibility
NOTE: Amikacin is the last to give out/least effected - decreased permeability = adaptive resistance
- Chromosomal resistance
-changes to 30S binding sites so mutations don’t usually produce clinical resistance
First exposure adaptive resistance
Bacteria takes up aminoglycosides initially and then there is a decrease in AG uptake for 1-2hours
*lasts up to 16hrs post exposure then partial return of susceptibility
-Resistance accumulates with increasing # of doses
Dosing to avoid first exposure adaptive resistance
Infrequent dosing of high doses
*this decreases the adaptive resistance effect
Amikacin vs. Gentamicin
Amikacin is more potent and broader (more gram negs but decreased Strep activity)
-less effected by bacterial resistance
Oral administration of aminoglycosides
Very poor!
-yet often found in calf scour boluses (very leaky gut due to damage= drug residues)
-some absorbed during enteritis or with high doses
Parenteral administration of aminoglycosides
Good absorption IM/SC
-but toxicity concerns so often given IV extralabel
Some systemic absorption IU (label) or IMM (ELDU) doses
Local delivery: hopefully minimal absorption